GCM
MYGN icon

Graham Capital Management’s Myriad Genetics MYGN Stock Holding History

Graham Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
61,480
+31,383
+104% +$164K 0.01% 847
2025
Q4 		$185K Buy
+30,097
New +$218K 0.01% 1065
2025
Q2 		– Sell
-71,349
Closed -$633K – 1514
2025
Q1 		$633K Buy
+71,349
New +$857K 0.02% 713
2024
Q4 		– Sell
-43,203
Closed -$1.18M – 1403
2024
Q3 		$1.18M Buy
43,203
+26,850
+164% +$727K 0.04% 416
2024
Q2 		$400K Buy
+16,353
New +$359K 0.01% 656
2023
Q3 		– Sell
-8,815
Closed -$204K – 1203
2023
Q2 		$204K Buy
+8,815
New +$192K 0.01% 812

Other funds holding MYGN

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.69B AUM 20.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return